Barth syndrome, a human disorder of cardiolipin metabolism

FEBS Letters

Volumn 580, Issue 23, 2006, Pages 5450-5455

  Schlame, Michael ^a   Ren, Mindong ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Fatty acid; Mitochondrial disease; Phospholipids; Skeletal muscle; Tafazzin

Indexed keywords

ACYLTRANSFERASE; CARDIOLIPIN; PHOSPHOLIPID;

BARTH SYNDROME; CLINICAL FEATURE; GENE MUTATION; GROWTH RETARDATION; HEART FAILURE; HUMAN; LIPID METABOLISM; MOLECULAR DYNAMICS; MYOPATHY; NEUTROPENIA; PRIORITY JOURNAL; SHORT SURVEY; X CHROMOSOME LINKAGE;

ANIMALS; CARDIOLIPINS; GENETIC DISEASES, X-LINKED; HUMANS; MITOCHONDRIA; SYNDROME; TRANSCRIPTION FACTORS;

EID: 33749061065     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.07.022     Document Type: Short Survey

References (52)

1. Barth P.G., van't Veer-Korthof E.T., van Delden L., van Dam K., van der Harten J.J., and Kuipers J.R.G. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. In: Busch H.F.M., Jennekens F.G.I., and Scholte H.R. (Eds). Mitochondria and Muscular Diseases (1981), Mefar, Beeststerzwaag 161-164
2. Barth P.G., Scholte H.R., Berden J.A., van der Klei-van Moorsel J.M., Luyt-Houwen I.E.M., van't Veer-Korthof E.T., van der Harten J.J., and Sobotka-Plojhar M.A. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. Neurol. Sci. 62 (1983) 327-355
3. Neustein H.B., Lurie P.R., Dahms B., and Takahashi M. An X-linked recessive cardiomyopathy with abnormal mitochondria. Pediatrics 64 (1979) 24-29
4. Ades L.C., Gedeon A.K., Wilson M.J., Latham M., Partington M.W., Mulley J.C., Nelson J., Lui K., and Sillence D.O. Barth syndrome: clinical features and confirmation of gene localization to distal Xq28. Am. J. Med. Genet. 45 (1993) 327-334
5. Cantlay A.M., Shokrollahi K., Allen J.T., Lunt P.W., Newbury-Ecob R.A., and Steward C.G. Genetic analysis of the G4.5 gene in families with suspected Barth syndrome. J. Pediatr. 135 (1999) 311-315
6. Chen R., Tsuji T., Ichida F., Bowles K.R., Yu X., Watanabe S., Hirono K., Tsubata S., Hamamichi Y., Ohta J., Imai Y., Bowles N.E., Miyawaki T., and Towbin J.A. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Mol. Genet. Metabol. 77 (2002) 319-325
7. Kelley R.I., Cheatham J.P., Clark B.J., Nigro M.A., Powell B.R., Sherwood G.W., Sladky J.T., and Swisher W.P. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J. Pediatr. 119 (1991) 738-747
8. Mazzocco M.M.M., and Kelley R.I. Preliminary evidence for a cognitive phenotype in Barth syndrome. Am. J. Med. Genet. 102 (2001) 372-378
9. Ichida F., Tsubata S., Bowles K.R., Haneda N., Uese K., Miyawaki T., Dreyer W.J., Messina J., Li H., Bowles N.E., and Towbin J.A. Novel gene mutation in patients with left ventricular noncompaction or Barth syndrome. Circulation 103 (2001) 1256-1263
10. Bolhuis P.A., Hensels G.W., Hulsebos T.J.M., Baas F., and Barth P.G. Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am. J. Hum. Genet. 48 (1991) 481-485
11. Bione S., D'Adamo P., Maestrini E., Gedeon A.K., Bolhuis P.A., and Toniolo D. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nature Genet. 12 (1996) 385-389
12. Bione S., Tamanini F., Maestrini E., Tribioli C., Poustka A., Torri G., Rivella S., and Toniolo D. Transcriptional organization of a 450-kb region of the human X chromosome in Xq28. Proc. Natl. Acad. Sci. USA 90 (1993) 10977-10981
13. D'Adamo P., Fassone L., Gedeon A., Janssen E.A., Bione S., Bolhuis P.A., Barth P.G., Wilson M., Haan E., Orstavik K.H., Patton M.A., Green A.J., Zammarchi E., Donati M.A., and Toniolo D. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am. J. Hum. Genet. 61 (1997) 862-867
14. Bleyl S.B., Mumford B.R., Thompson V., Carey J.C., Pysher T.J., Chin T.K., and Ward K. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am. J. Hum. Genet. 61 (1997) 868-872
15. Johnston J., Kelley R.I., Feigenbaum A., Cox G.F., Iyer G.S., Funanage V.L., and Proujansky R. Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am. J. Hum. Genet. 61 (1997) 1053-1058
16. Lu B., Kelher M.R., Lee D.P., Lewin T.M., Coleman R.A., Choy P.C., and Hatch G.M. Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues. Biochem. Cell Biol. 82 (2004) 569-576
17. Gonzalez I.L. Barth syndrome: TAZ gene mutations, mRNAs, and evolution. Am. J. Med. Genet. 134A (2005) 409-414
18. Neuwald A.F. Barth syndrome may be due to an acyltransferase deficiency. Curr. Biol. 7 (1997) R465-R466
19. Vreken P., Valianpour F., Nijtmans L.G., Grivell L.A., Plecko B., Wanders R.J.A., and Barth P.G. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279 (2000) 378-382
20. Schlame M., Rua D., and Greenberg M.L. The biosynthesis and functional role of cardiolipin. Progr. Lipid Res. 39 (2000) 257-288
21. Schlame M., and Rustow B. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. Biochem. J. 272 (1990) 589-595
22. Valianpour F., Mitsakos V., Schlemmer D., Towbin J.A., Taylor J.M., Ekert P.G., Thorburn D.R., Munnich A., Wanders R.J.A., Barth P.G., and Vaz F.M. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J. Lipid Res. 46 (2005) 1182-1195
23. Gu Z., Valianpour F., Chen S., Vaz F.M., Hakkaart G.A., Wanders R.J.A., and Greenberg M.L. Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome. Mol. Microbiol. 51 (2004) 149-158
24. Schlame M., Towbin J.A., Heerdt P.M., Jehle R., DiMauro S., and Blanck T.J.J. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann. Neurol. 51 (2002) 634-637
25. Schlame M., Kelley R.I., Feigenbaum A., Towbin J.A., Heerdt P.M., Schieble T., Wanders R.J.A., DiMauro S., and Blanck T.J.J. Phospholipid abnormalities in children with Barth syndrome. J. Am. Coll. Cardiol. 42 (2003) 1994-1999
26. Valianpour F., Wanders J.A., Barth P.G., Overmars H., and van Gennip A.H. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients. Clin. Chem. 48 (2002) 1390-1397
27. Valianpour F., Wanders R.J.A., Overmars H., Vreken P., van Gennip A.H., Baas F., Plecko B., Santer R., Becker K., and Barth P.G. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): A study in cultured skin fibroblasts. J. Pediatr. 141 (2002) 729-733
28. Kuijpers T.W., Maianski N.A., Tool A.T.J., Becker K., Plecko B., Valianpour F., Wanders R.J.A., Pereira R., van Hove J., Verhoeven A.J., Roos D., Baas F., and Barth P.G. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 103 (2004) 3915-3923
29. Xu Y., Sutachan J.J., Plesken H., Kelley R.I., and Schlame M. Characterization of lymphoblast mitochondria from patients with Barth syndrome. Lab. Invest. 85 (2005) 823-830
30. Valianpour F., Wanders R.J.A., Overmars H., Vaz F.M., Barth P.G., and van Gennip A.H. Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment. J. Lipid Res. 44 (2003) 560-566
31. Xu Y., Kelley R.I., Blanck T.J.J., and Schlame M. Remodeling of cardiolipin by phospholipid transacylation. J. Biol. Chem. 278 (2003) 51380-51385
32. Vaz F.M., Houtkooper R.H., Valianpour F., Barth P.G., and Wanders R.J.A. Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism. J. Biol. Chem. 278 (2003) 43089-43094
33. Xu, Y., Condell, M., Plesken, H., Edelman-Novemsky, I., Ma, J., Ren, M. and Schlame, M. (in press) A Drosophila model of Barth syndrome. Proc. Natl. Acad. Sci. USA.
34. Schlame M., Ren M., Xu Y., Greenberg M.L., and Haller I. Molecular symmetry in mitochondrial cardiolipins. Chem. Phys. Lipids 138 (2005) 38-49
35. Kraffe E., Soudant P., Marty Y., Kervarec N., and Jehan P. Evidence of tetradocosahexaenoic cardiolipin in some marine bivalves. Lipids 37 (2002) 507-514
36. Powell G.L., and Jacobus J. The nonequivalence of the phosphorus atoms in cardiolipin. Biochemistry 13 (1974) 4024-4026
37. Lands W.E.M. Metabolism of glycerolipids. II. The enzymatic acylation of lysolecithin. J. Biol. Chem. 235 (1960) 2233-2237
38. Taylor W.A., and Hatch G.M. Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J. Biol. Chem. 278 (2003) 12716-12721
39. Cao J., Liu Y., Lockwood J., Burn P., and Shi Y. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acylttansferase (ALCAT1) in mouse. J. Biol. Chem. 279 (2004) 31727-31734
40. Testet E., Laroche-Traineau J., Noubhani A., Coulon D., Bunoust O., Camougrand N., Manon S., Lessire R., and Bessoule J.-J. Ypr140wp, 'the yeast tafazzin', displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesis. Biochem. J. 387 (2005) 617-626
41. Ma L., Vaz F.M., Gu Z., Wanders R.J.A., and Greenberg M.L. The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Δ mutant. Implications for Barth syndrome. J. Biol. Chem. 279 (2004) 44394-44399
42. Schlame M., Shanske S., Doty S., Konig T., Sculco T., DiMauro S., and Blanck T.J.J. Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease. J. Lipid Res. 40 (1999) 1585-1592
43. 1 complex structure. EMBO J. 20 (2001) 6591-6600
44. Pebay-Peyroula E., Dahout-Gonzalez C., Kahn R., trezeguet V., Lauquin G.J., and Brandolin G. Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 426 (2003) 39-44
45. Zhang M., Mileykovskaya E., and Dowhan W. Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J. Biol. Chem. 277 (2002) 43553-43556
46. Pfeiffer K., Gohil V., Stuart R.A., Hunte C., Brandt U., Greenberg M.L., and Schagger H. Cardiolipin stabilizes respiratory chain supercomplexes. J. Biol. Chem. 278 (2003) 52873-52880
47. Brandner K., Mick D.U., Frazier A.E., Taylor R.D., Meisinger C., and Rehling P. Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: Implications for Barth syndrome. Mol. Biol. Cell 16 (2005) 5202-5214
48. Schlame M., and Haldar D. Cardiolipin is synthesized on the matrix side of the inner membrane of rat liver mitochondria. J. Biol. Chem. 268 (1993) 74-79
49. Bissler J.J., Tsoras M., Goring H.H.H., Hug P., Chuck G., Tombragel E., McGraw C., Schlotman J., Ralston M.A., and Hug G. Infantile dilated X-linked cardiomyopathy, G4.5 mutations, altered lipids, and ultrastructural malformations of mitochondria in heart, liver, and skeletal muscle. Lab. Invest. 82 (2002) 335-344
50. Davey K.M., Parboosingh J.S., McLeod D.R., Chan A., Casey R., Ferreira P., Snyder F.F., Bridge P.J., and Bernier F.P. Mutation of DNAJC19, a human homolog of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition. J. Med. Gen. 43 (2006) 385-393
51. De Kremer R.D., Paschini-Capra A., Bacman S., Argarana C., Civallero G., Kelley R.I., Guelbert N., Latini A., Noher de Halac I., Giner-Ayala A., Johnston J., Proujansky R., Gonzalez I., Depetris-Boldini C., Oller-Ramirez A., Angaroni C., Theaux R.A., Hliba E., and Juaneda E. Barth's syndrome-like disorder: a new phenotype with a maternally inherited A3243G substitution of mitochondrial DNA (MELAS mutation). Am. J. Med. Gen. 99 (2001) 83-93
52. Vendelin M., Beraud N., Guerrero K., Andrienko T., Kuznetsov A.V., Olivares J., Kay L., and Saks V.A. Mitochondrial regular arrangement in muscle cells: a "crystal-like" pattern. Am. J. Physiol. Cell Physiol. 288 (2005) C757-C767